SCHEMBL7269073

SCHEMBL7269073

O=C(O)C(Cc1ccccc1)C(O)C(Cc1ccccc1)C(=O)O

nearest known ligand 0.66

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
SLC1A3 P43003 2/20 0.66
SLC1A2 P43004 2/20 0.66
SLC1A1 P43005 2/20 0.66
CYP1A2 P05177 1/20 0.59
ALPI P09923 1/20 0.55
PKM P14618 1/20 0.55
PTGS1 P23219 1/20 0.55
XIAP P98170 1/20 0.55
SLC7A5 Q01650 1/20 0.55
CPA1 P15085 6/20 0.52
CPA3 P15088 3/20 0.52
FOLH1 Q04609 1/20 0.52
CPB1 P15086 1/20 0.52
CPB2 Q96IY4 1/20 0.52
SRR Q9GZT4 2/20 0.50
NPSR1 Q6W5P4 1/20 0.48
HSD17B10 Q99714 1/20 0.48
MDM2 Q00987 1/20 0.48
ACE P12821 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
(2R,3R)-2,3-Dibenzylsuccinic Acid SCHEMBL305323 0.89 SLC1A3 (0.73) SLC1A3SLC1A2SLC1A1CYP1A2ALPI
(2R,3R)-2,3-Dibenzylsuccinic Acid SCHEMBL2919214 0.89 SLC1A3 (0.73) SLC1A3SLC1A2SLC1A1CYP1A2ALPI
(2R,3R)-2,3-Dibenzylsuccinic Acid SCHEMBL7289849 0.89 SLC1A3 (0.73) SLC1A3SLC1A2SLC1A1CYP1A2ALPI
(2R,3R)-2,3-Dibenzylsuccinic Acid SCHEMBL4755513 0.89 SLC1A3 (0.73) SLC1A3SLC1A2SLC1A1CYP1A2ALPI
SCHEMBL14318901 0.88 SLC1A3 (0.58) SLC1A3SLC1A2SLC1A1CYP1A2ALPI
SCHEMBL3866544 0.85 SLC1A3 (0.63) SLC1A3SLC1A2SLC1A1CYP1A2ALPI
SCHEMBL7436297 0.85 SLC1A3 (0.63) SLC1A3SLC1A2SLC1A1CYP1A2ALPI
SCHEMBL3867023 0.85 SLC1A3 (0.63) SLC1A3SLC1A2SLC1A1CYP1A2ALPI
SCHEMBL2243422 0.85 SLC1A3 (0.63) SLC1A3SLC1A2SLC1A1CYP1A2ALPI
SCHEMBL24252143 0.83 SLC1A3 (0.61) SLC1A3SLC1A2SLC1A1CYP1A2ALPI

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0839798-A2 Intermediates for preparating non-peptide retroviral protease inhibitors ABBOTT LABORATORIES (US) 1998-05-06 EP disclosed
US-5670675-A Retroviral protease inhibiting compounds ABBOTT LABORATORIES (US) 1997-09-23 US disclosed
US-5545750-A TREATING HUMAN IMMUNODEFICIENCY VIRUS ABBOTT LABORATORIES (US) 1996-08-13 US disclosed
US-5142056-A Human immunodeficiency virus protease inhibitor ABBOTT LABORATORIES (US) 1992-08-25 US disclosed
EP-0402646-A1 Retroviral protease inhibiting compounds ABBOTT LABORATORIES (US) 1990-12-19 EP disclosed